EntityQ321431· pop 14abirateroneSign in to saveREDIRECT Abiraterone acetateResearch4,108 papersAbiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.Lancet (London, England) · 2022Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.The Lancet. Oncology · 2023Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.NEJM evidence · 2022Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study.Annals of oncology : official journal of the European Society for Medical Oncology · 2026AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.The New England journal of medicine · 2014via PubMedArticleREDIRECT Abiraterone acetateConnectionsabiraterone acetateEntity